Clinical Trials

Classical hematologyGastrointestinal

30 enrolled

Hepatic Veno-Occlusive Disease, Colorectal Neoplasms, Chemical and Drug Induced Liver Injury

NCT06743555 2026-04-28

SAVED LUNG

Phase 1 Not yet recruiting

14 enrolled

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

NCT07549399 2026-04-24

CRITⅡ

204 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Rectal Neoplasms

NCT07515924 2026-04-07

Oral Gallium Maltolate for Recurrent Glioblastoma

8 enrolled

CNS

Glioblastoma

NCT07472478 2026-03-16

GIVEN

32 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07432802 2026-02-27

STRADOS

182 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06448286 2026-02-19

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

60 enrolled

CNS

Glioblastoma

NCT07384884 2026-02-19

SLITT-GBM

12 enrolled

CNS

Brain Neoplasms

NCT07402538 2026-02-11

Surgery With or Without Neoadjuvant Treatment of SBRT Plus Chemoimmunotherapy in Resectable Locally Advanced Oral and HPV-unrelated Oropharyngeal Squamous Cell Carcinoma

184 enrolled

Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07383142 2026-02-06

Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2)

202 enrolled

Thymic epithelial tumor

NCT07253168 2025-11-28

TIGER-BC

240 enrolled

Breast

Breast Neoplasms

NCT07241819 2025-11-21

Ivonescimab Monotherapy or in Combination With Chemotherapy as Neoadjuvant/Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

66 enrolled

II-IIIB (T3N2) Resectable Non-small Cell Lung Cancer

NCT07208526 2025-10-06

A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST

270 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT07200141 2025-09-30

SIB-NCRT-pumch

156 enrolled

Locally Advanced Rectal Adenocarcinoma

NCT07177092 2025-09-16

SURGAN-TKI

118 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07162714 2025-09-09

STAR

30 enrolled

Rectal Neoplasms

NCT07145931 2025-08-28

Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base

24 enrolled

Head and Neck Cancer Squamous Cell Carcinoma

NCT07089199 2025-07-28

TitAN

34 enrolled

NSCLC

NCT07038460 2025-06-26

NEO-LISI

134 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Resectable Non-small Cell Lung Cancer

NCT07028918 2025-06-19

NCLDR

35 enrolled

Acidemia, isovaleric, Squamous Cell Carcinoma of Head and Neck

NCT06646445 2025-06-13

PREMICES

60 enrolled

Turcot syndrome, Colonic Neoplasms, Microsatellite Instability

NCT06998719 2025-05-31

ACCESS

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06957938 2025-05-08

Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma

168 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms

NCT06958601 2025-05-06

Safety and Efficacy of Transoral Robotic Thyroidectomy Versus Traditional Open Thyroidectomy for Thyroid Cancer

400 enrolled

Thyroid Neoplasms

NCT06944470 2025-04-25

JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC

76 enrolled

NSCLC

NCT06919510 2025-04-09

A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer

90 enrolled

Rectal Neoplasms

NCT06837948 2025-02-20

Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC

160 enrolled

Locally Advanced Non-Small Cell Lung Cancer

NCT06814067 2025-02-07

Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma

80 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT06796348 2025-01-28

Radiofrequency Ablation Versus Hemithyroidectomy of Small Thyroid Cancers

88 enrolled

Thyroid Neoplasms

NCT06751394 2024-12-27

TRACER

44 enrolled

Rectal Neoplasms

NCT06746103 2024-12-24

RELIEVE

250 enrolled

Spinal Metastasis

NCT06591910 2024-09-19

Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06599827 2024-09-19

iMHRT-LARC

54 enrolled

Rectal Neoplasms

NCT06603974 2024-09-19

EASOBFGE

48 enrolled

Stomach Neoplasms

NCT06578871 2024-09-03

SUPERIOR

90 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms

NCT06487767 2024-07-05

The Validity of the Use of Imaging in Cervical Cancer Staging

100 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06282536 2024-02-28

Neoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC: A Single Arm, Exploratory Trial

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06109402 2023-12-19

Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer

160 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05993858 2023-08-15

PC-1

33 enrolled

Phase 4 Not yet recruiting

Squamous Cell Carcinoma of Head and Neck

NCT05843292 2023-06-06

NeoSTEP

48 enrolled

Breast

Triple Negative Breast Neoplasms

NCT05891080 2023-06-06

Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial

124 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05496166 2023-05-17

The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer

348 enrolled

Limited Stage Small Cell Lung Cancer

NCT05794750 2023-04-06

AK104-IIT-13

50 enrolled

Colorectal Neoplasms

NCT05747482 2023-02-28

Omentectomy vs Omental Preservation in Resectable Cancer

569 enrolled

Stomach Neoplasms

NCT05671809 2023-01-05

ARF-RC

402 enrolled

Rectal Neoplasms

NCT05648487 2022-12-16

HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal Metastasis

46 enrolled

Phase 2/3 Not yet recruiting

Stomach Neoplasms

NCT05144100 2021-12-03

SCOPE

498 enrolled

Tumor-Agnostic

Carcinoma

NCT04531930 2020-08-31

Colorectal Adenoma Canceration in FAP

124 enrolled

Adenomatous Polyposis Coli

NCT04465968 2020-07-10

DEEP_OCEAN

84 enrolled